The clinical value of serum sirtuin-1 in the diagnosis of rheumatoid arthritis: a pilot study

References

• Aletaha D, Smolen J-S. Diagnosis and management of rheumatoid arthritis: A review. J Amer Med Assoc. 2018;320:1360–1372.
   PubMed Web of Science ®Google Scholar
• Smolen J-S, Daniel A, McInnes I-B. Rheumatoid arthritis. Lancet. 2016;388:2023–2038.
   PubMed Web of Science ®Google Scholar
• North B-J, Eric V. Sirtuins: sir2-related NAD-dependent protein deacetylases. Genome Biol. 2004;5:224.
   PubMed Web of Science ®Google Scholar
• Engler A, Tange C, Frank-Bertoncelj M, et al. Regulation and function of SIRT1 in rheumatoid arthritis synovial fibroblasts. J Mol Med. 2016;94:173–182.
   PubMed Web of Science ®Google Scholar
• Zhang C, Fang L, Liu X, et al. miR-22 inhibits synovial fibroblasts proliferation and proinflammatory cytokine production in RASF via targeting SIRT1. Gene. 2020;724:144144.
   PubMed Web of Science ®Google Scholar
• Kong S, Yeung P, Fang D. The class III histone deacetylase sirtuin 1 in immune suppression and its therapeutic potential in rheumatoid arthritis. J Genet Genomics. 2013;40:347–354.
   PubMed Web of Science ®Google Scholar
• Grabiec AM, Krausz S, de Jager W, et al. Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis patient synovial macrophages and tissue. J Immunol. 2010;184:2718–2728.
   PubMed Web of Science ®Google Scholar
• Niederer F, Ospelt C, Brentano F, et al. SIRT1 overexpression in the rheumatoid arthritis synovium contributes to proinflammatory cytokine production and apoptosis resistance. Ann Rheum Dis. 2011;70:1866–1873.
   PubMed Web of Science ®Google Scholar
• Combe B, Robert L, Claire-I D, et al. 2016 update of the EULAR recommendations for the management of early arthritis. Ann Rheum Dis. 2017;76:948–959.
   PubMed Web of Science ®Google Scholar
• Ward M-M, Atul D, Akl EA, et al. 2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis research and treatment network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheumatol. 2019;71:1599–1613.
   PubMed Web of Science ®Google Scholar
• van Middelkoop M, Bennell KL, Callaghan MJ. International patellofemoral osteoarthritis consortium: consensus statement on the diagnosis, burden, outcome measures, prognosis, risk factors and treatment[J]. Semin Arthritis Rheum. 2018;5:666–675.
   Google Scholar
• Shiboski C-H, Stephen-C S, Raphaèle S, et al. 2016 American College of Rheumatology/European League against rheumatism classification criteria for primary sjögren’s syndrome: a consensus and data‐driven methodology involving three international patient cohorts. Arthritis Rheumatol. 2016;69:35–45.
   PubMed Web of Science ®Google Scholar
• Littlejohn E-A, Monrad S-U, Diagnosis E. Treatment of Rheumatoid Arthritis. Prim Care. 2018;45:237–255.
   PubMed Web of Science ®Google Scholar
• Derksen V-F-A-M, Huizinga T-W-J, van der Woude D. The role of autoantibodies in the pathophysiology of rheumatoid arthritis. Semin Immunopathol. 2017;39:437–446.
   PubMed Web of Science ®Google Scholar
• Esalatmanesh K, Raika J, Arsia J, et al. Serum anti-cyclic citrullinated peptide antibodies may predict disease activity in rheumatoid arthritis. Rheumatol Int. 2012;32:3799–3805.
   PubMedGoogle Scholar
• Zhu J-N, Liu-Yan N, Xiao-Yong L, et al. Meta-analysis: compared with anti-CCP and rheumatoid factor, could anti-MCV be the next biomarker in the rheumatoid arthritis classification criteria?. Clin Chem Lab Med. 2019;57:1668–1679.
   PubMed Web of Science ®Google Scholar
• Damjanovska L, Thabet -M-M, Levarth E-W-N, et al. Diagnostic value of anti-MCV antibodies in differentiating early inflammatory arthritis. Ann Rheum Dis. 2010;69:730–732.
   PubMed Web of Science ®Google Scholar
• Wang G, Xinxin X, Lingli Y, et al. Resveratrol ameliorates rheumatoid arthritis via activation of SIRT1‐Nrf2 signaling pathway. BioFactors. 2020;46:441–453.
   PubMed Web of Science ®Google Scholar
• Guoqing L, Zhongbing X, Ying L, et al. SIRT1 inhibits rheumatoid arthritis fibroblast-like synoviocyte aggressiveness and inflammatory response via suppressing NF-κB pathway. Biosci Rep. 2018;38:4–13.
   Web of Science ®Google Scholar